全文获取类型
收费全文 | 1297751篇 |
免费 | 95597篇 |
国内免费 | 2138篇 |
专业分类
耳鼻咽喉 | 18467篇 |
儿科学 | 42959篇 |
妇产科学 | 38476篇 |
基础医学 | 189271篇 |
口腔科学 | 36056篇 |
临床医学 | 109997篇 |
内科学 | 256309篇 |
皮肤病学 | 26976篇 |
神经病学 | 100218篇 |
特种医学 | 50760篇 |
外国民族医学 | 375篇 |
外科学 | 201698篇 |
综合类 | 27164篇 |
现状与发展 | 2篇 |
一般理论 | 320篇 |
预防医学 | 94155篇 |
眼科学 | 29730篇 |
药学 | 99778篇 |
1篇 | |
中国医学 | 2643篇 |
肿瘤学 | 70131篇 |
出版年
2018年 | 13004篇 |
2016年 | 10778篇 |
2015年 | 12421篇 |
2014年 | 17009篇 |
2013年 | 25616篇 |
2012年 | 35270篇 |
2011年 | 37711篇 |
2010年 | 22119篇 |
2009年 | 20766篇 |
2008年 | 36073篇 |
2007年 | 39109篇 |
2006年 | 39532篇 |
2005年 | 38683篇 |
2004年 | 37239篇 |
2003年 | 36083篇 |
2002年 | 35554篇 |
2001年 | 58372篇 |
2000年 | 59847篇 |
1999年 | 50929篇 |
1998年 | 14368篇 |
1997年 | 12913篇 |
1996年 | 13157篇 |
1995年 | 12442篇 |
1994年 | 11822篇 |
1993年 | 10911篇 |
1992年 | 41100篇 |
1991年 | 40456篇 |
1990年 | 39982篇 |
1989年 | 38799篇 |
1988年 | 36192篇 |
1987年 | 35432篇 |
1986年 | 33801篇 |
1985年 | 32208篇 |
1984年 | 23977篇 |
1983年 | 20892篇 |
1982年 | 12404篇 |
1981年 | 10966篇 |
1979年 | 22702篇 |
1978年 | 15919篇 |
1977年 | 13774篇 |
1976年 | 13007篇 |
1975年 | 14239篇 |
1974年 | 16716篇 |
1973年 | 16094篇 |
1972年 | 15338篇 |
1971年 | 14250篇 |
1970年 | 13228篇 |
1969年 | 12746篇 |
1968年 | 11989篇 |
1967年 | 10491篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
3.
4.
Abd-Allah H. El Ashmawy Kathleen Dowson Ahmed El-Bakoury Hazem A.H. Hosny Rathan Yarlagadda Jonathan Keenan 《The Journal of arthroplasty》2021,36(3):816-822.e1
BackgroundTotal hip and knee arthroplasties are increasingly performed operations, and routine follow-up places huge demands on orthopedic services. This study investigates the effectiveness, patients’ satisfaction, and cost reduction of Virtual Joint Replacement Clinic (VJRC) follow-up of total hip arthroplasty and total knee arthroplasty patients in a university hospital. VJRC is especially valuable when in-person appointments are not advised or feasible such as during the COVID-19 pandemic.MethodsA total of 1749 patients who were invited for VJRC follow-up for knee or hip arthroplasty from January 2017 to December 2018 were included in this retrospective study. Patients were referred to VJRC after their 6-week postoperative review. Routine VJRC postoperative review was undertaken at 1 and 7 years and then 3-yearly thereafter. We evaluated the VJRC patient response rate, acceptability, and outcome. Patient satisfaction was measured in a subgroup of patients using a satisfaction survey. VJRC costs were calculated compared to face-to-face follow-up.ResultsThe VJRC had a 92.05% overall response rate. Only 7.22% required further in-person appointments with only 3% being reviewed by an orthopedic consultant. VJRC resulted in an estimated saving of £42,644 per year at our institution. The patients’ satisfaction survey showed that 89.29% of the patients were either satisfied or very satisfied with VJRC follow-up.ConclusionVJRC follow-up for hip and knee arthroplasty patients is an effective alternative to in-person clinic assessment which is accepted by patients, has high patient satisfaction, and can reduce the cost to both health services and patients. 相似文献
5.
6.
Kara S. Tanaka MD Veronica R. Andaya BA Steven W. Thorpe MD Kenneth R. Gundle MD James B. Hayden MD Yee-Cheen Duong MD Raffi S. Avedian MD David G. Mohler MD Lee J. Morse MD Melissa N. Zimel MD Richard J. O'Donnell MD Andrew Fang MD Robert Lor Randall MD Tina H. Tran BS Christin New BA Rosanna L. Wustrack MD other members of Study Group FORCE 《Journal of surgical oncology》2023,127(1):148-158
7.
Major depressive disorder and other neuropsychiatric disorders are often managed with long-term use of antidepressant medication. Fluoxetine, an SSRI antidepressant, is widely used as a first-line treatment for neuropsychiatric disorders. However, fluoxetine has also been shown to increase the risk of metabolic diseases such as non-alcoholic fatty liver disease. Fluoxetine has been shown to increase hepatic lipid accumulation in vivo and in vitro. In addition, fluoxetine has been shown to alter the production of prostaglandins which have also been implicated in the development of non-alcoholic fatty liver disease. The goal of this study was to assess the effect of fluoxetine exposure on the prostaglandin biosynthetic pathway and lipid accumulation in a hepatic cell line (H4-II-E-C3 cells). Fluoxetine treatment increased mRNA expression of prostaglandin biosynthetic enzymes (Ptgs1, Ptgs2, and Ptgds), PPAR gamma (Pparg), and PPAR gamma downstream targets involved in fatty acid uptake (Cd36, Fatp2, and Fatp5) as well as production of 15-deoxy-Δ12,14PGJ2 a PPAR gamma ligand. The effects of fluoxetine to induce lipid accumulation were attenuated with a PTGS1 specific inhibitor (SC-560), whereas inhibition of PTGS2 had no effect. Moreover, SC-560 attenuated 15-deoxy-Δ12,14PGJ2 production and expression of PPAR gamma downstream target genes. Taken together these results suggest that fluoxetine-induced lipid abnormalities appear to be mediated via PTGS1 and its downstream product 15d-PGJ2 and suggest a novel therapeutic target to prevent some of the adverse effects of fluoxetine treatment. 相似文献
8.
9.
Timothy J. Cordingley Mark A.G. Wilson Kathryn M. Weston 《Health & social care in the community》2022,30(1):353-359
Vaccination is a vital health care initiative to prevent individual and population infection. To increase vaccination rates the federal government implemented the ‘No Jab, No Pay’ policy, where eligibility for several government benefits required children to be fully vaccinated by removing ‘conscientious objections’ and expanding the age range of children whose families receive benefits. This study assesses the impact of this policy at a local area within a single medical practice community in NSW, Australia. A retrospective clinical audit was performed between 2012 and 2017 on a single general practice's vaccination records for children ≤19 years. Catch-up vaccinations were assessed based on age at vaccination. Incidence of catch-up vaccinations was assessed for each of four years before and two years after the implementation of the ‘No Jab, No Pay’ policy in January 2016, along with the age of children and vaccination(s) given. Catch-up vaccinations were assessed temporally either side of implementation of ‘No Jab, No Pay’. Comparing the average annual vaccination catch-up incidence rate of 6.2% pre-implementation (2012–2015), there was an increase to 9.2% in 2016 (p < .001) and 7.8% in 2017 (p = .027). Secondary outcome measurement of catch-up vaccination incidence rates before (2012–2015) and after (2016–2017) ‘No Jab, No Pay’ implementation showed statistically significant increases for children aged 8–11 years (3.2%–5.6%, p = .038), 12–15 years (7.5%–14.7%, p < .001) and 16–19 years (3.3%–10.2%, p < .001) along with a statistically significant reduction in children aged 1–3 years (11.4%–6.2%, p = .015). Also, catch-up rates for DTPa significantly increased after program implementation. This study demonstrates that the Australian federal government vaccination policy ‘No Jab, No Pay’ was coincident with an increase in catch-up vaccinations within a rural NSW community served by one medical practice, especially for older children. 相似文献
10.